Linoleic acid or LA or 18:2n-6 is a member of the group of lipids known as unsaturated fatty acids. It has 18 carbon atoms and two cis double bonds at positions 9 and 12. Since the first double bond, with respect to the methyl end, is located at position 6, it is an omega-6 polyunsaturated fatty acid (PUFA) or omega-6 fatty acid.
Linoleic acid, from the Latin linon, meaning flax, plus oleic, meaning oil, was isolated by Sacc F. in 1844 from linseed oil, the structure was clarified by Hilditch T.P. et al. in 1939, and was synthesized by Raphael R.A. and Sondheimer F. in 1950.
Many animals, including humans, can’t synthesize it. For these animals, linoleic acid and alpha-linolenic acid or ALA, which is the precursor of omega-3 polyunsaturated fatty acids or omega-3 fatty acids, are essential fatty acids, that is, fatty acids that must be obtained from the diet. Moreover, in the absence of dietary LA, the other omega-6 PUFAs gamma-linolenic acid, dihomo-gamma-linolenic acid, arachidonic acid or ARA, and adrenic acid become essential, too, as it is their precursor. For this reason, they are defined as conditionally essential fatty acids.
Like the other fatty acids, it is rarely found in free form; most commonly it is bound through ester bonds to organic molecules such as sterols, glycerol, and glycerol 3-phosphate to form more complex lipids, such as sterol esters, for example cholesterol esters, triglycerides, and phospholipids.
In humans, it is abundantly found in adipose tissue and plasma lipoproteins.
It performs many functions both directly and indirectly through its metabolites. It may be used for energy. It is a structural component of cell membranes. It is involved in the maintenance of transepidermal water barrier. It serves as precursor for the synthesis of omega-6 polyunsaturated fatty acids. It may be desaturated to alpha-linolenic acid in vascular terrestrial plants and phytoplankton. Like ARA and docosahexaenoic acid or DHA, an omega-3 fatty acid, linoleic acid serves as precursor for the synthesis of bioactive lipid mediators. Finally, it has been shown that dietary LA intake is inversely related to the risk of coronary heart disease.
It is the most abundant PUFA in the Western diet, and is the only one whose intake is significantly increased, whereas the intake of the other omega-6 and omega-3 fatty acids have remained relatively constant since the early 1900s, corresponding to less than 1% of the daily energy intake. The high LA intake has shifted the omega-6 to omega-3 ratio from 4:1 to 20:1.
Linoleic acid deficiency results in retardation in growth and wound healing, dermatitis, reproductive problems, fatty liver and polydipsia. However, its deficiency is extremely rare due to its abundance in the Western diet, and consequently in breast milk, and to its presence in baby formulas.
The main dietary sources are soybean, corn, sunflower, canola and safflower oils.
Properties, names and identifiers
Molecular weight: 280.447 g/mol
Molecular formula: C18H32O2
Melting point: -5 °C (23 °F; 268.15 K)
Boiling point: 230 °C (446 °F; 503.15 K) at 16 mm Hg
IUPAC name: (9Z,12Z)-octadeca-9,12-dienoic acid
CAS registry number: 60-33-3
European Community (EC) Number: 200-470-9
In purified form it is a colorless oil.
- Synthesis of linoleic acid
- Distribution of linoleic acid
- Linoleic acid metabolites
- Role of linoleic acid
- Food sources
- New cultivars
Synthesis of linoleic acid
Linoleic acid is synthesized from oleic acid, an unsaturated fatty acid with a chain of 18 carbon atoms and a cis double bond at position 9 with respect to the methyl end, therefore an omega-9 fatty acid.
The reaction, catalyzed by delta-12 desaturase (EC 184.108.40.206), introduces a second cis double bond between the 12th and 13th carbon atom, and is the critical step in omega-6 PUFA biosynthesis.
It should be underscored that delta-12 desaturase catalyzes the shift from an omega-9 fatty acid to an omega-6 fatty acid.
It was long thought that this enzyme was present only in Bacteria, Protozoa and Plants, and that only these organisms were able to synthesize linoleic acid. However, in 1961 it was shown that an insect, the American cockroach Periplaneta americana, was able to synthesize linoleic acid. Subsequently, LA synthesis was detected in other insects and other invertebrates, including several Nematodes, Crustaceans and Acari.
Distribution of linoleic acid
Linoleic acid, with palmitic acid and oleic acid, is one of the most abundant fatty acids in triglycerides of adipose tissue and plasma lipoproteins, where its concentration reflects dietary intake. In the USA, the large increase in dietary LA intake has been accompanied by an increase in its content in adipose tissue, which has been estimated >130%. Due to its abundance and susceptibility to oxidation, linoleic acid is the fatty acid that is most commonly oxidized in LDLs. And oxidation of LDL lipids is a risk factor for coronary heart disease.
Although essential for fetal neurodevelopment, it is present in low concentrations in the brain, less than 2% of total fatty acids, much lower than palmitic acid, stearic acid, oleic acid, DHA and ARA, which account for over 84% of brain fatty acids.
It is the most abundant PUFA in the epidermis.
Linoleic acid metabolites
Linoleic acid is the precursor of all omega-6 fatty acids.
It can be desaturated to alpha-linolenic acid, the precursor of omega-3 PUFAs. The reaction is catalyzed by delta-15 desaturase (EC 220.127.116.11), that is present only in the plastids and in the endoplasmic reticulum of phytoplankton and vascular terrestrial plants. It should be underscored that delta-15 desaturase catalyzes the shift from an omega-6 fatty acid to an omega-3 fatty acid.
It is the precursor of bioactive lipid mediators with autocrine and paracrine effect, which are involved in the regulation of many cellular processes. Similarly to arachidonic acid and docosahexaenoic acid, when released from membrane phospholipids, it may be oxidized in reactions catalyzed by enzymes such as 12-lipoxygenase (EC 18.104.22.168), 15-lipoxygenase (EC 22.214.171.124), cyclooxygenases (EC 126.96.36.199), soluble epoxy hydrolase (EC 188.8.131.52), and by enzymes of the cytochrome P450 family, namely, the same enzymes involved in the metabolism of ARA and DHA. It may be also oxidized by free radicals, too. The mediators produced, such as epoxy- and mono-, di-, and trihydroxy derivatives, which are called oxidized linoleic acid metabolites (OXLAMs), are involved in cell signaling and regulation of pain and inflammation.
Because linoleic acid can be converted to arachidonic acid, which is the precursor of bioactive lipid mediators, some with anti-inflammatory activities or able to promote the resolution of inflammatory injuries, others with pro-inflammatory activities, it was hypothesized that tissue levels of ARA could be reduced by reducing LA intake. However, at least in subjects who consume a typical Western diet, this does not seem to occur, as LA conversion to ARA is very modest, between 0.3% and 0.6%, similarly to what occurs in the conversion of ALA to DHA. Furthermore, it has been suggested that the profile of lipid mediators, as well as inflammatory response to a diet rich in linoleic acid are influenced by the FADS1 genotype, where FADS1 gene encodes for delta-5 desaturase (EC 184.108.40.206), the enzyme that catalyzes the second desaturation reaction of arachidonic acid synthesis pathway, that is, the desaturation of dihomo-gamma-linolenic acid to ARA.
Role of linoleic acid
For most animals, including humans, linoleic acid is an essential fatty acid, and plays important roles acting either directly or through its metabolites.
- It can be used as an energy source. For example, it enters the brain at a rate comparable to that of DHA, ARA and other fatty acids. ARA and DHA are mostly incorporated into membrane phospholipids whereas almost 60% of linoleic acid is oxidized by the beta-oxidation pathway. Furthermore, part of the acetate produced is used for cholesterol synthesis within the brain.
- As a component of membrane phospholipids, it is involved in the maintenance of membrane fluidity.
- As a component of membrane sphingolipids, it is involved in the formation and maintenance of the water permeability barrier of the skin.
- It can bind to and activate PPARα.
This transcription factor plays a major role in metabolic regulation. For example, it inhibits the transcription of genes coding for enzymes involved in lipogenesis, and activates the transcription of gene coding for enzymes involved in lipolysis and in mitochondrial and lysosomal beta-oxidation. In this way, linoleic acid may reduce plasma levels of total and LDL cholesterol, thus contributing to the reduction of cardiovascular risk.
During the twentieth century the consumption of vegetable oils rich in linoleic acid is increased 20-fold in the United States. This increase was due to:
- the development of cultivars that produce seeds with high LA content, particularly soy and corn;
- an increased commercial availability of the derived oils;
- dietary recommendations to increase its consumption as an aid to lower blood cholesterol levels, recommendations resulting from studies by the American physiologist Ancel Keys in the mid-1950s.
This has led LA intake to the current levels of about 6% of total dietary energy, compared to pre-1930s values, that ranged between 1 to 2% of total dietary energy.
In the US diet, soybean oil is the major LA dietary source, accounting for about 45% of its dietary intake.
Other foods rich in linoleic are acid corn, sunflower, safflower, and canola oils and the corresponding seeds, as well as walnuts, peanuts, cottonseed and sesame seeds.
Animals fed with diets rich in linoleic acid can also be a good source.
It is the most abundant PUFA in foods. The highest values are found again in soybean oil, where it accounts for up to 88% of total PUFAs, and exceeds 70% of the total PUFAs in the most commonly consumed foods. For example, it ranges between 75 and 85% of the total PUFAs in pork, beef and chicken meats, and exceeds 80% in eggs. Moreover, it is the major PUFA in vegetables, fruits, and grains, that is, foods with a low fat content. The exception is beans where it accounts for 40-50% of the total PUFAs.
In nature, linoleic acid is synthesized in concentrations comparable to those of alpha-linolenic acid.
Although in the 1930s cultivars have been selected that produce seeds with high LA content, in recent years this trend is changing as new cultivars have been selected to produce seeds with a lower LA content. Moreover, for the most part linoleic acid has been replaced by oleic acid. This has allowed to obtain not only sunflower and safflower oils with high oleic acid content instead of high LA content, but also soybeans with high oleic acid content. And as the new cultivars will replace the traditional cultivars, a reduction in the consumption of linoleic acid in favor of oleic acid will presumably occur. This could shift the levels of LA intake back to levels comparable to those at the beginning of the 1900s. This transition could bring health benefits as the consumption of oleic acid is associated with improvements in HDL cholesterol levels. It should be underscored that a good dietary intake of oleic acid, in the form of extra virgin olive oil, is a feature of the Mediterranean Diet.
Akoh C.C. and Min D.B. Food lipids: chemistry, nutrition, and biotechnology. 3th Edition. CRC Press, Taylor & Francis Group, 2008
Blasbalg T. L., Hibbeln J. R., Ramsden C. E., Majchrzak S. F. & Rawlings R. R. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. Am J Clin Nutr 2011;93(5):950-962. doi:10.3945/ajcn.110.006643
Chow Ching K. Fatty acids in foods and their health implication. 3th Edition. CRC Press, Taylor & Francis Group, 2008
Farvid M.S., Ding M., Pan A., Sun Q., Chiuve S.E., Steffen L.M., Willett W.C., Hu F.B. Dietary linoleic acid and risk of coronary heart disease: a systematic review and meta-analysis of prospective cohort studies. Circulation 2014;130:1568-1578. doi:10.1161/CIRCULATIONAHA.114.010236
Guyenet S.J., Carlson S.E. Increase in adipose tissue linoleic acid of US adults in the last half century. Adv Nutr 2015;6(6):660-664. doi:https://DOI.org/10.3945/an.115.009944
Jandacek R.J. Linoleic acid: a nutritional quandary. Healthcare 2017;5(2):25. doi:10.3390/healthcare5020025
Lankinen M.A., Fauland A., Shimizu B., Agren J., Wheelock C.E., Laakso M., Schwab U., and Pihlajamaki J. Inflammatory response to dietary linoleic acid depends on FADS1 genotype. Am J Clin Nutr 2019;109:165-175. doi:10.1093/ajcn/nqy287
Malcicka M., Visser B., Ellers J. An evolutionary perspective on linoleic acid synthesis in animals. Evol Biol 2018;45:15-26. doi:10.1007/s11692-017-9436-5
Schuster S. Johnson C.D, Hennebelle M., Holtmann T., Taha A.Y., Kirpich I.A., Eguchi A., Ramsden C.E., Papouchado B.G., McClain C.J., Feldstein A.E. Oxidized linoleic acid metabolites induce liver mitochondrial dysfunction, apoptosis and NLRP3 activation in mice. J Lipid Res 2018;59(9):1597-1609. doi:10.1194/jlr.M083741
Taha A.Y. Linoleic acid-good or bad for the brain? NPJ Sci Food 2020;4:1. doi:10.1038/s41538-019-0061-9
Whelan J. and Fritsche K. Linoleic acid. Adv Nutr 2013;4(3): 311-312. doi:10.3945/an.113.003772